Breast MR imaging

doi:10.1017/CBO9780511978968.005

Chapter 3 - Breast MR imaging

Published online by Cambridge University Press: 05 August 2011

Savannah C. Partridge ,

Habib Rahbar and

Constance D. Lehman

Edited by

Ihab R. Kamel and

Elmar M. Merkle

Show author details

Ihab R. Kamel: Affiliation:
The Johns Hopkins University School of Medicine
Elmar M. Merkle: Affiliation:
Duke University School of Medicine, North Carolina

Book contents

Get access

Summary

Introduction

The move to higher magnetic field strength holds promise for advancing magnetic resonance (MR) imaging of the breast. Potential benefits include higher signal-to-noise ratio (SNR), contrast, and spectral resolution, which could translate into higher spatial and temporal resolution than previously possible. However, technical, physical, and safety considerations present challenges for fully realizing these benefits for breast MR imaging.

Background on clinical utility of breast MR imaging

MR imaging has proven to be a valuable imaging tool in detecting, characterizing, and assessing the extent of breast cancer. However, due to the relatively higher costs ofMR imaging when compared to mammography and ultrasound, judicious use for specific clinically proven applications is essential. Current evidence-based clinical applications of breast MR imaging include screening high-risk patients (including patients with a known geneticmutation such as BRCA or with a greater than 20% lifetime risk based on family history), evaluating patients with a new diagnosis of breast cancer, monitoring response to neoadjuvant chemotherapy, evaluation of patients with metastatic axillary adenocarcinoma of unknown primary, and evaluation of silicone implants suspected of rupture.

Type: Chapter
Information: Body MR Imaging at 3 Tesla , pp. 26 - 33

DOI: https://doi.org/10.1017/CBO9780511978968.005 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rakow-Penner, RDaniel, BYu, HSawyer-Glover, AGlover, GHRelaxation times of breast tissue at 1.5T and 3T measured using IDEALJ Magn Reson Imaging 2006 23 87CrossRef Google Scholar PubMed

Rohrer, MBauer, HMintorovitch, JRequardt, MWeinmann, HJComparison of magnetic properties of MRI contrast media solutions at different magnetic field strengthsInvest Radiol 2005 40 715CrossRef Google Scholar PubMed

Barth, MMSmith, MPPedrosa, ILenkinski, RERofsky, NMBody MR imaging at 3.0 T: understanding the opportunities and challengesRadiographics 2007 27 1445CrossRef Google Scholar

Kuhl, CKKooijman, HGieseke, JSchild, HHEffect of B1 inhomogeneity on breast MR imaging at 3.0 TRadiology 2007 244 929CrossRef Google Scholar PubMed

Azlan, CADi Giovanni, PAhearn, TSB1 transmission-field inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced MRI (DCE-MRI) of the breast at 3TJ Magn Reson Imaging 2010 31 234CrossRef Google Scholar PubMed

Kuhl, CKJost, PMorakkabati, NContrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experienceRadiology 2006 239 666CrossRef Google Scholar

Pinker, KGrabner, GBogner, WA combined high temporal and high spatial resolution 3Tesla MR imaging protocol for the assessment of breast lesions: initial resultsInvest Radiol 2009 44 553CrossRef Google Scholar

Wiesinger, FVan de Moortele, PFAdriany, GPotential and feasibility of parallel MRI at high fieldNMR Biomed 2006 19 368CrossRef Google Scholar PubMed

Ladd, MEHigh-field-strength magnetic resonance: potential and limitsTop Magn Reson Imaging 2007 18 139CrossRef Google Scholar PubMed

Rakow-Penner, RHargreaves, BGlover, GHDaniel, BBreast MRI at 3TAppl Radiol 2009 38 6Google Scholar

Guo, YCai, YQCai, ZLDifferentiation of clinically benign and malignant breast lesions using diffusion-weighted imagingJ Magn Reson Imaging 2002 16 172CrossRef Google Scholar PubMed

Woodhams, RMatsunaga, KKan, SADC mapping of benign and malignant breast tumorsMagn Reson Med Sci 2005 4 35CrossRef Google Scholar PubMed

Partridge, SCDeMartini, WBKurland, BFQuantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive valueAJR Am J Roentgenol 2009 193 1716CrossRef Google Scholar PubMed

Matsuoka, AMinato, MHarada, MComparison of 3.0- and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancerRadiat Med 2008 26 15CrossRef Google Scholar PubMed

Lo, GGAi, VChan, JKDiffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3TComput Assist Tomogr 2009 33 63CrossRef Google Scholar

Bolan, PJNelson, MTYee, DGarwood, MImaging in breast cancer: magnetic resonance spectroscopyBreast Cancer Res 2005 7 149CrossRef Google Scholar PubMed

Sinha, SSinha, URecent advances in breast MRI and MRSNMR Biomed 2009 22 3CrossRef Google Scholar PubMed

Haddadin, ISMcIntosh, AMeisamy, SMetabolite quantification and high-field MRS in breast cancerNMR Biomed 2009 22 65CrossRef Google Scholar PubMed

Meisamy, SBolan, PJBaker, EHNeoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy – a pilot study at 4 TRadiology 2004 233 424CrossRef Google Scholar PubMed

Peters, NHMeeuwis, CBakker, CJFeasibility of MRI-guided large-core-needle biopsy of suspiscious breast lesions at 3 TEur Radiol 2009 19 1639CrossRef Google Scholar PubMed

Book contents

Chapter 3 - Breast MR imaging

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive